Literature DB >> 9738979

Surgical significance of telomerase activity in noncancerous liver tissue from patients with hepatocellular carcinoma.

T Kanamaru1, Y Morita, T Itoh, M Yamamoto, Y Kuroda, H Hisatomi.   

Abstract

Telomerase activity has been detected in tissue from noncancerous liver of patients with chronic liver disease, but its functional significance remains to be elucidated. We therefore evaluated the telomerase activity in surgically obtained noncancerous liver tissue from 20 hepatocellular carcinoma (HCC) patients. Two samples of noncancerous liver tissue were obtained from each patient: one from the parenchyma adjacent to the HCC nodules of the resected specimen; the other from the parenchyma distant from the HCC nodules of the remnant liver. Telomerase activity was assayed by a non-radioisotope quantitative system based on "TRAP-eze." Five samples from the noncancerous liver tissue adjacent to the HCC nodules (25.0%) were telomerase-positive; all such cases showed high-grade malignant potential, such as intrahepatic metastasis and/or portal vascular invasion and infiltration of the fibrous capsule in the corresponding HCC nodules, and telomerase positivity showed neither a relationship with the histological activity index scores nor a correlation with liver function. Interestingly, no telomerase activity was detected in any of the 20 samples obtained from the parenchyma of the remnant liver. These results indicate that telomerase in noncancerous liver tissue is associated not with the hepatic condition accompanying HCC, but with the biological characteristics of the tumor itself, and may derive from infiltrating cancer cells. Determination of telomerase status may aid in designing more effective surgical procedures.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9738979      PMCID: PMC5921885          DOI: 10.1111/j.1349-7006.1998.tb03277.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  18 in total

1.  Telomerase catalytic subunit homologs from fission yeast and human.

Authors:  T M Nakamura; G B Morin; K B Chapman; S L Weinrich; W H Andrews; J Lingner; C B Harley; T R Cech
Journal:  Science       Date:  1997-08-15       Impact factor: 47.728

Review 2.  Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis.

Authors:  R A Weinberg
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

3.  Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma.

Authors:  R Nakashio; M Kitamoto; H Tahara; T Nakanishi; T Ide; G Kajiyama
Journal:  Int J Cancer       Date:  1997-04-22       Impact factor: 7.396

4.  Activation of telomerase in human lymphocytes and hematopoietic progenitor cells.

Authors:  K Hiyama; Y Hirai; S Kyoizumi; M Akiyama; E Hiyama; M A Piatyszek; J W Shay; S Ishioka; M Yamakido
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

Review 5.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

6.  Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.

Authors:  N Miura; I Horikawa; A Nishimoto; H Ohmura; H Ito; S Hirohashi; J W Shay; M Oshimura
Journal:  Cancer Genet Cytogenet       Date:  1997-01

7.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

8.  Telomerase activity in hepatocellular carcinoma as a predictor of postoperative recurrence.

Authors:  K Ohta; T Kanamaru; Y Morita; Y Hayashi; H Ito; M Yamamoto
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

9.  Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease.

Authors:  H Kojima; O Yokosuka; F Imazeki; H Saisho; M Omata
Journal:  Gastroenterology       Date:  1997-02       Impact factor: 22.682

10.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.